查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1821697

2025年产前DNA定序全球市场报告

Prenatal DNA Sequencing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年产前DNA定序市场将快速成长，到2029年将达到52.3亿美元，年复合成长率（CAGR）为16.6%。预测期内的成长动力包括消费者对早期检测的需求、产妇年龄增长和怀孕风险的增加、公共卫生倡议、监管支持和指南以及数据分析的进步。预测期内的主要趋势包括研发倡议、伦理和监管考虑、数据解读工具的改进、精准医疗的整合以及产前遗传咨询。

未来五年16.6%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。贸易摩擦可能导致德国和中国开发的高通量定序系统和生物资讯软体价格上涨，阻碍美国全基因组胎儿定序的普及，导致交付时间延长和遗传咨询成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，贸易摩擦的影响可能更为广泛。

癌症发生率的预期上升将推动产前DNA定序市场的成长。癌症的特征是细胞不受控制地生长和扩散，这促使人们使用产前DNA定序来检测胎儿非整倍体并识别胎儿癌症。这种定序方法可以揭示影响个体癌症易感性的遗传或生殖系DNA变化。例如，根据美国癌症协会2023年1月的数据，预计癌症病例数将从2021年的1,898,160例增加3.16%，到2023年将达到1,958,310例。因此，癌症疫情正在推动产前DNA定序市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球产前DNA定序：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球产前DNA定序市场：成长率分析
  • 全球产前DNA定序市场表现：规模与成长，2019-2024年
  • 全球产前DNA定序市场预测：规模与成长，2024-2029年，2034年
  • 全球产前 DNA 定序：总潜在市场（TAM）

第六章 市场细分

  • 全球产前DNA定序市场：依类型、绩效及预测，2019-2024年、2024-2029年、2034年
  • 遗传性疾病
  • 非遗传性疾病
  • 全球产前DNA定序市场：应用、绩效及预测（2019-2024年、2024-2029年及2034年）
  • 血友病
  • 唐氏症
  • 囊肿纤维化
  • 自闭症
  • Dijorglus症候群
  • 爱滋病（爱滋病）
  • 癌症
  • 其他用途
  • 全球产前 DNA 定序市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究
  • 临床研究
  • 医院和诊所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球产前 DNA 定序市场：依遗传疾病类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 单基因疾病
  • 染色体异常
  • 全球产前 DNA 定序市场：依非遗传疾病（类型）细分、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 母亲的健康状况

第七章 区域和国家分析

  • 全球产前DNA定序市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球产前DNA定序市场：依国家、绩效及预测，2019-2024年、2024-2029年、2034年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 产前DNA定序市场：竞争格局
  • 产前DNA定序市场：公司简介
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Natera Inc.
  • Myriad Genetics Inc.
  • Invitae Corporation
  • PerkinElmer Inc.
  • Macrogen Inc.
  • Pacific Biosciences of California Inc.
  • Genewiz LLC
  • 10x Genomics Inc.
  • Oxford Nanopore Technologies Limited
  • Thermo Fisher Scientific Inc.
  • Berry Genomics Co. Ltd.
  • Centrillion Technology Holdings Corp.
  • Cynvenio Biosystems Inc.
  • Eurofins LifeCodexx AG
  • GeneDx Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年产前DNA定序市场：哪些国家将提供新机会
  • 2029年产前DNA定序市场：细分领域带来新机会
  • 2029年产前DNA定序市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r23667u

Prenatal DNA sequencing is a method employed to sequence the DNA of an unborn baby, utilizing a blood sample from the mother to unveil the complete genetic code of the fetus. This technique is instrumental in detecting fetal disorders or diseases.

The primary types of prenatal DNA sequencing encompass genetic diseases and nonhereditary diseases. Genetic diseases refer to disorders or diseases caused by mutations in one or more genes. DNA sequencing plays a crucial role in determining whether a gene carries a mutation leading to a specific disorder. Applications of prenatal DNA sequencing include conditions such as hemophilia, Down syndrome, cystic fibrosis, autism, DiGeorge syndrome, AIDS, cancer, and others. Various users, including academic research, clinical research, hospitals and clinics, as well as pharmaceutical and biotechnology companies, employ this technology.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The prenatal DNA sequencing market research report is one of a series of new reports from The Business Research Company that provides prenatal DNA sequencing market statistics, including the prenatal DNA sequencing industry global market size, regional shares, competitors with a prenatal DNA sequencing market share, detailed prenatal DNA sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal DNA sequencing industry. This prenatal DNA sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal dna sequencing market size has grown rapidly in recent years. It will grow from $2.5 billion in 2024 to $2.82 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to changing patient preferences, medical advancements and research, non-invasive testing adoption, rising maternal age, improved accuracy and reliability.

The prenatal dna sequencing market size is expected to see rapid growth in the next few years. It will grow to $5.23 billion in 2029 at a compound annual growth rate (CAGR) of 16.6%. The growth in the forecast period can be attributed to consumer demand for early detection, rising maternal age and pregnancy risks, public health initiatives, regulatory support and guidelines, advancements in data analysis. Major trends in the forecast period include research and development efforts, ethical and regulatory considerations, improved data interpretation tools, precision medicine integration, prenatal genetic counseling.

The forecast of 16.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of whole-genome fetal sequencing by inflating prices of high-throughput sequencing systems and bioinformatics software developed in Germany and China, resulting in slower turnaround times and higher genetic counseling costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated rise in cancer prevalence is set to drive the growth of the prenatal DNA sequencing market. Cancer, characterized by uncontrolled cell growth and spread, prompts the use of prenatal DNA sequencing to detect fetal aneuploidy and identify cancer in the fetus. This sequencing method unveils inherited or germline DNA changes influencing a person's cancer susceptibility. For example, data from the American Cancer Society in January 2023 showed an increase in cancer cases from 1,898,160 in 2021 to 1,958,310 in 2023, reflecting a growth rate of 3.16%. Consequently, the prevalence of cancer acts as a driving force for the prenatal DNA sequencing market.

The increasing birth rate is anticipated to drive the growth of the prenatal DNA sequencing market in the coming years. The birth rate refers to the number of live births per 1,000 individuals in a specific population over a defined period, typically reported annually. Prenatal DNA sequencing is instrumental in detecting genetic abnormalities in unborn fetuses, facilitating informed reproductive choices during childbirth through selective interventions. For example, in January 2023, a report from the Centers for Disease Control and Prevention, a U.S.-based national public health organization, indicated that the United States experienced a 1% rise in registered births, amounting to 3,664,292, compared to the previous year. Consequently, the increasing birth rate is propelling the prenatal DNA sequencing market.

Product innovation is a prominent trend in the prenatal DNA sequencing market, with major companies concentrating on developing innovative solutions to enhance their market standing. Juno Diagnostics, Inc., a U.S.-based health technology company, introduced the noninvasive prenatal screening test 'Hazel' in November 2022. Designed with no risk of miscarriage, the test can be performed as early as 9 weeks into pregnancy using a small blood sample. It screens for common genetic conditions such as Down syndrome, Edwards syndrome, and Patau syndrome.

Major companies in the prenatal DNA sequencing market are pursuing a strategic partnership approach to improve technology integration and broaden their market presence. A strategic partnership generally involves a collaborative relationship among two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For example, in December 2023, BillionToOne, a U.S.-based precision diagnostics company, teamed up with a Johnson & Johnson subsidiary, a U.S.-based pharmaceutical firm, for the AZALEA Phase 3 clinical trial of nipocalimab. This trial focuses on pregnancies at risk for severe hemolytic disease of the fetus and newborn (HDFN). BillionToOne will supply its UNITY Fetal Antigen Non-invasive Prenatal Test (UNITY Fetal Antigen CTA) to screen and determine participant eligibility. HDFN is a rare condition resulting from blood type incompatibility between the pregnant individual and the fetus, which can lead to life-threatening anemia.

In November 2022, Myriad Genetics, Inc., a U.S.-based provider of genetic testing and precision medicine, acquired Gateway Genomics, LLC, a personal genomics and prenatal DNA company. The undisclosed acquisition is expected to enhance Myriad's women's health product portfolio and provide access to personalized genetic tests, strengthening its position in the market.

Major companies operating in the prenatal DNA sequencing market include Agilent Technologies Inc., BGI Group, F. Hoffmann-La Roche Ltd, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., Myriad Genetics Inc., Invitae Corporation, PerkinElmer Inc., Macrogen Inc., Pacific Biosciences of California Inc., Genewiz LLC, 10x Genomics Inc., Oxford Nanopore Technologies Limited, Thermo Fisher Scientific Inc., Berry Genomics Co. Ltd., Centrillion Technology Holdings Corp., Cynvenio Biosystems Inc., Eurofins LifeCodexx AG, GeneDx Inc., Genoma SA, Helix OpCo LLC, Igenomix S.L., Integrated DNA Technologies Inc.

North America was the largest region in the prenatal DNA sequencing market in 2024. The regions covered in the prenatal dna sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal dna sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The prenatal DNA sequencing market includes revenues earned by entities by provide services such as prenatal next-generation sequencing, whole genome sequencing, DNA extraction, DNA fragmentation, and data collection and sequence analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal DNA Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal dna sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal dna sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The prenatal dna sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Genetic Diseases; Nonhereditary Diseases
  • 2) By Application: Hemophilia; Down Syndrome; Cystic Fibrosis; Autism; DiGeorge Syndrome; AIDS (Acquired Immunodeficiency Syndrome); Cancer; Other Applications
  • 3) By End User: Academic Research; Clinical Research; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Genetic Diseases: Monogenic Disorders; Chromosomal Abnormalities
  • 2) By Nonhereditary Diseases: Infectious Diseases; Maternal Health Conditions
  • Companies Mentioned: Agilent Technologies Inc.; BGI Group; F. Hoffmann-La Roche Ltd; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; Myriad Genetics Inc.; Invitae Corporation; PerkinElmer Inc.; Macrogen Inc.; Pacific Biosciences of California Inc.; Genewiz LLC; 10x Genomics Inc.; Oxford Nanopore Technologies Limited; Thermo Fisher Scientific Inc.; Berry Genomics Co. Ltd.; Centrillion Technology Holdings Corp.; Cynvenio Biosystems Inc.; Eurofins LifeCodexx AG; GeneDx Inc.; Genoma SA; Helix OpCo LLC; Igenomix S.L.; Integrated DNA Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal DNA Sequencing Market Characteristics

3. Prenatal DNA Sequencing Market Trends And Strategies

4. Prenatal DNA Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prenatal DNA Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Prenatal DNA Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Prenatal DNA Sequencing Market Growth Rate Analysis
  • 5.4. Global Prenatal DNA Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Prenatal DNA Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Prenatal DNA Sequencing Total Addressable Market (TAM)

6. Prenatal DNA Sequencing Market Segmentation

  • 6.1. Global Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Diseases
  • Nonhereditary Diseases
  • 6.2. Global Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemophilia
  • Down Syndrome
  • Cystic Fibrosis
  • Autism
  • DiGeorgre Syndrome
  • AIDS (Acquired Immunodeficiency Syndrome)
  • Cancer
  • Other Applications
  • 6.3. Global Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research
  • Clinical Research
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users
  • 6.4. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Genetic Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monogenic Disorders
  • Chromosomal Abnormalities
  • 6.5. Global Prenatal DNA Sequencing Market, Sub-Segmentation Of Nonhereditary Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Maternal Health Conditions

7. Prenatal DNA Sequencing Market Regional And Country Analysis

  • 7.1. Global Prenatal DNA Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Prenatal DNA Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal DNA Sequencing Market

  • 8.1. Asia-Pacific Prenatal DNA Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal DNA Sequencing Market

  • 9.1. China Prenatal DNA Sequencing Market Overview
  • 9.2. China Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal DNA Sequencing Market

  • 10.1. India Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal DNA Sequencing Market

  • 11.1. Japan Prenatal DNA Sequencing Market Overview
  • 11.2. Japan Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal DNA Sequencing Market

  • 12.1. Australia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal DNA Sequencing Market

  • 13.1. Indonesia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal DNA Sequencing Market

  • 14.1. South Korea Prenatal DNA Sequencing Market Overview
  • 14.2. South Korea Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal DNA Sequencing Market

  • 15.1. Western Europe Prenatal DNA Sequencing Market Overview
  • 15.2. Western Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal DNA Sequencing Market

  • 16.1. UK Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal DNA Sequencing Market

  • 17.1. Germany Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal DNA Sequencing Market

  • 18.1. France Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal DNA Sequencing Market

  • 19.1. Italy Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal DNA Sequencing Market

  • 20.1. Spain Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal DNA Sequencing Market

  • 21.1. Eastern Europe Prenatal DNA Sequencing Market Overview
  • 21.2. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal DNA Sequencing Market

  • 22.1. Russia Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal DNA Sequencing Market

  • 23.1. North America Prenatal DNA Sequencing Market Overview
  • 23.2. North America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal DNA Sequencing Market

  • 24.1. USA Prenatal DNA Sequencing Market Overview
  • 24.2. USA Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal DNA Sequencing Market

  • 25.1. Canada Prenatal DNA Sequencing Market Overview
  • 25.2. Canada Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal DNA Sequencing Market

  • 26.1. South America Prenatal DNA Sequencing Market Overview
  • 26.2. South America Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal DNA Sequencing Market

  • 27.1. Brazil Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal DNA Sequencing Market

  • 28.1. Middle East Prenatal DNA Sequencing Market Overview
  • 28.2. Middle East Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal DNA Sequencing Market

  • 29.1. Africa Prenatal DNA Sequencing Market Overview
  • 29.2. Africa Prenatal DNA Sequencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Prenatal DNA Sequencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Prenatal DNA Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal DNA Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal DNA Sequencing Market Competitive Landscape
  • 30.2. Prenatal DNA Sequencing Market Company Profiles
    • 30.2.1. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. BGI Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal DNA Sequencing Market Other Major And Innovative Companies

  • 31.1. Natera Inc.
  • 31.2. Myriad Genetics Inc.
  • 31.3. Invitae Corporation
  • 31.4. PerkinElmer Inc.
  • 31.5. Macrogen Inc.
  • 31.6. Pacific Biosciences of California Inc.
  • 31.7. Genewiz LLC
  • 31.8. 10x Genomics Inc.
  • 31.9. Oxford Nanopore Technologies Limited
  • 31.10. Thermo Fisher Scientific Inc.
  • 31.11. Berry Genomics Co. Ltd.
  • 31.12. Centrillion Technology Holdings Corp.
  • 31.13. Cynvenio Biosystems Inc.
  • 31.14. Eurofins LifeCodexx AG
  • 31.15. GeneDx Inc.

32. Global Prenatal DNA Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal DNA Sequencing Market

34. Recent Developments In The Prenatal DNA Sequencing Market

35. Prenatal DNA Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Prenatal DNA Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Prenatal DNA Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Prenatal DNA Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer